Ryan Preblick
Director of Finance/CFO bei INDIVIOR PLC
Vermögen: 1 Mio $ am 31.03.2024
Profil
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INDIVIOR PLC
0,05% | 15.03.2024 | 68 386 ( 0,05% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Ryan Preblick
| Unternehmen | Position | Beginn |
|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 29.06.2020 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Ausbildung von Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
